Navigation Links
Stemedica Issued U.S. Patent For Stem Cell Treatment of Diabetic Retinopathy and Diabetic Optic Neuropathy
Date:12/20/2012

ing and prevent the leakage of the microvasculature. The ischemic tolerant neural stem cells, injected directly behind the eye, address the nerve damage that has occurred with this condition.”

The patent was enabled by the results of a six patient clinical study conducted by Natalia Gavrilova, M.D., Ph.D., Head of Vascular & Eye Neurology at the Fyodorov Eye Microsurgery Center of Russia, and Professor and Chairman of the Department of Ophthalmology of Moscow Medical University. Fyodorov is one of the leading ophthalmologic centers in the world performing over 300,000 procedures a year.

The study, presented at the Association for Research in Vision and Ophthalmology meeting in Florida in the spring of 2011, was conducted without adverse events. Patients experienced improvements in the function of the optic nerve, blood flow to the eye, and reduction of inflammation in the six-month period following injection and became stable for the entire follow up period.

Paul Tornambe, M.D., of Retinal Consultants Inc., in San Diego, California, and former President of the American Society of Retina Specialists, reviewed the data. According to Dr. Tornambe, “These preliminary data are encouraging. As we seek to find the best treatments for diabetic retinopathy, it is important to explore many different approaches including combined stem cell treatment.”

Maynard Howe, Ph.D., Vice Chairman and Chief Executive Officer of Stemedica commented, “One of the strategic advantages of Stemedica is our ability to manufacture, under cGMP conditions and with the appropriate licensure, multiple types of stem cells and to do so with proven safety, purity and potency. We look forward to utilizing our ischemic tolerant products in addressing eye-related disease.”

About Stemedica Cell Technologies, Inc.
Stemedica Cell Technologies, Inc. is a specialty bio-pharmaceutical company committed to the manufacturing and development of best-in-class allo
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. 12th U.S. Patent Issued To Dyadic International
2. Saladax Biomedical, Inc. Issued Six Patents Containing Broad Claims in the Immunoassay Space
3. Enbrel® (etanercept) Patent Issued
4. DNA2.0 Patents New DNA Cloning Method
5. Puritan Awarded U.S. Patent for High-Performance HydraFlock® Swab
6. RiboMed Receives Three Additional Patents for Disease Diagnostics Methods
7. Sequenom, Inc. Announces Issuance Of Patent For Methods Of Detecting Fetal Aneuploidy
8. RiboMed Receives Three Additional Patents for Disease Diagnostics Methods
9. Amarantus BioSciences Wins MANF Patent Challenge in Europe
10. Revolutionary Tetrapod Quantum Dot Synthesis US Patent Granted
11. Cardium Announces Patent Award For Rights To Cardiovascular Gene Therapy For The Treatment Of Heart Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2013)... and TEL AVIV, Israel , May 24, ... "Company") (NYSE MKT: NSPR), a leader in embolic protection stents, ... President and Chief Executive Officer, and Craig Shore ... the Benchmark Company, LLC One-on-One Investor Conference on Thursday May ... Milwaukee, WI. The format ...
(Date:5/24/2013)... May 24, 2013 Senomyx , Inc. ... taste science technologies to discover, develop, and commercialize novel ... , Ph.D., the Company,s Vice President, Biology and ... Relations & Corporate Communications, will present an overview of ... 10:25 a.m. Eastern Time (7:25 a.m. Pacific Time) during ...
(Date:5/24/2013)... (PRWEB) May 24, 2013 This ... survey on kinase profiling carried out in May ... of the breakdown of the responses for each ... future (2015). It also highlights some interesting differences, ... groupings. Two bottom-up models were developed to estimate ...
(Date:5/24/2013)... (PRWEB) May 24, 2013 Many factors ... and uptake or efflux transporters at the blood-tissue barrier. ... related to unbound fractions in the tissue rather than ... these disposition challenges is required to guide lead optimization, ... identify any species-dependent variables that may impact the likely ...
Breaking Biology Technology:InspireMD To Participate In Benchmark Investor Conference On May 30th 2InspireMD To Participate In Benchmark Investor Conference On May 30th 3InspireMD To Participate In Benchmark Investor Conference On May 30th 4SENOMYX TO WEBCAST CORPORATE PRESENTATION AT THE CITI 2013 GLOBAL CONSUMER CONFERENCE 2Kinase Market Profiling - In House & Outsourced Trends 2015 Forecast in New Research Report at ReportsnReports.com 2Kinase Market Profiling - In House & Outsourced Trends 2015 Forecast in New Research Report at ReportsnReports.com 3Kinase Market Profiling - In House & Outsourced Trends 2015 Forecast in New Research Report at ReportsnReports.com 4DMPK for Targeted Tissue Delivery: Solutions for the Most Challenging Part of Outsourcing, New Life Science Webinar Hosted by Xtalks 2
... Market, According to a ... New Report from Decision Resources, WALTHAM, Mass., Oct. 17 ... that Merck,will obtain blockbuster antidiabetic drug sales in the type 2 ... will see rapid uptake as a second-and third-line agent in type ...
... Kyphon Inc.,(Nasdaq: KYPH ) announced today that its ... Inc. (NYSE: MDT ) at a special,meeting of ... 26, 2007, Kyphon entered into a,definitive merger agreement with ... the outstanding shares of Kyphon common stock for,$71.00 per ...
... LAWRENCE, Mass., Oct. 16 NxStage Medical,Inc. (Nasdaq: ... plans to release its financial results for the third,quarter ... of the,financial markets. NxStage will also host a ... 2007 to discuss its third quarter 2007 financial results. ...
Cached Biology Technology:Merck Will Obtain Blockbuster Antidiabetic Drug Sales in Type 2 Diabetes Market by 2011 2Merck Will Obtain Blockbuster Antidiabetic Drug Sales in Type 2 Diabetes Market by 2011 3Kyphon Stockholders Approve Merger with Medtronic 2NxStage(R) Medical to Report Third Quarter 2007 Financial Results on Friday, November 2nd 2
(Date:5/24/2013)... in one French Quarter neighborhood of New Orleans to ... Annette Hurley, PhD, Assistant Professor of Audiology at LSU ... third-year LSUHSC doctor of audiology student, recommend that people ... Their case study is published online in the current ... "An important part of an audiologist,s practice is aiding ...
(Date:5/24/2013)... the search for medication against Alzheimer,s disease, scientists have focused ... down Amyloid beta (A-beta). After all, it is the accumulation ... of Alzheimer,s patients. Starting point for the formation of A-beta ... the first to unravel the function of APPL the ... fruit flies. , Alessia Soldano (VIB/KU Leuven): "We have ...
(Date:5/24/2013)... A conference of 500 leading water scientists from around ... major reforms, "in the short span of one or ... on Earth will be living under the handicap of ... resource for which there is no substitute. This handicap ... , The scientists bluntly pointed to chronic underlying problems ...
Breaking Biology News(10 mins):Please do try this at home 2A new strategy required in the search for Alzheimer's drugs? 2A majority on Earth face severe self-inflicted water woes within 2 generations: Scientists 2A majority on Earth face severe self-inflicted water woes within 2 generations: Scientists 3A majority on Earth face severe self-inflicted water woes within 2 generations: Scientists 4
... ?a region in the brain linked to emotion and feelings ... the Jan. 26 issue of the journal Science. , The ... , It also raises the possibility that other ... circuits for pleasure. , The senior authors of the ...
... could help control weight, lower fat and cholesterol levels, and ... Chemistry & Industry, the magazine of the SCI. , Yellow ... this is one of the reasons why frozen food manufacturer ... a team of Korean researchers has shown that black soya ...
... with more than a decade’s worth of statistics, researchers are ... gay and bisexual men. , The overall number of syphilis ... to just 7,177 in 2003 perhaps because of a nationwide ... their rates rise significantly in this decade. , ...
Cached Biology News:Smokers quit after damage to brain region 2Syphilis rate on rise in US gay, bisexual men 2
Mouse monoclonal [DJR3] to DcR1 (Biotin) ( Abpromise for all tested applications). entrezGeneID: 8794 SwissProtID: O14798...
... most comprehensive, cost-effective solution to your ... unprecedented quality into both our products ... detection chemistries and antibodies that have ... It also includes our competitively priced ...
... RED Chromogen System consists of ... buffer. FAST RED reacts in ... to produce red staining with ... The FAST RED tablets ...
Mouse Cell Line Slides...
Biology Products: